A day trip thru the medical swamp: sites, acronyms, costs,

New Post Public Reply Private Reply Replies (1) Message Board
WBeacham
478
A day trip thru the medical swamp: sites, acronyms, costs, jargon, options, menus, privatize me!, and other assorted mind-blowing garbage. IOW, anything besides clear, understandable information presented in a way that an average human being might have a chance of deciphering their inflated medical bill. This is what is facing BIEL as they try their level best to obtain the prized CPT code for insurance billing and coverage. And you wonder why they need outside help (consultants) to navigate this quagmire? Stay tuned and read on if you dare. It ain't pretty.

I typed in "CPT I codes" to search using DuckDuckGo search engine. I think BIEL has a better than average chance of getting the CPT I code but who really knows, eh? Will they try only for RRx or try for PEMF in general? Does it make a difference if RRx is prescription only? Does this low vs high frequency play into it? I opened the AMA site, then the CPT option. I know, I should have known better. The following is typical of why the med system is such a fawckin' mess.
Quote:
Medicine’s language—CPT—opens for developers to test innovations - Digital health startups got nearly << $30 billion >> last year, but too often turn out products that burden doctors. AMA effort aims to help change that.

Yea, good luck w/ that. $30 billion for health startups, whatever that means. Go ahead, click on it, see what you get. It's sickening to read. All about helping doctors, like they need it, and practically nothing about providing, you know, actual healthcare to the patient.

Back to the CPT business. The actual wording of requirements for a CPT I are encouraging. The following link gives a decent, understandable rundown of CPT categories I & III. It looks like it is from 2019 so it is 3 yrs old. Items (a) - (f) are the CPT I requirements.

https://medicarepaymentandreimbursement.com/2...s-and.html

a) the service/procedure necessary for the procedure has received approval from the Food and Drug Administration (FDA) for the specific use of devices or drugs;

b) the suggested procedure/service is a distinct service performed by many physicians or other qualified health professionals across the United States;

c) the suggested service/procedure and clinical efficacy of the service/procedure is well established and documented in peer review literature that meets the requirements set in the code change proposal form;

d) the suggested service/procedure is performed with the frequency consistent with the intended clinical use;

e) the suggested service/procedure is neither a fragmentation of an existing procedure/service nor currently reportable by one or more existing codes; and

f) the procedure or service is consistent with current medical practice.

These fit us (BIEL) like a glove. Now you can see why we are so keen to get physicians (and practices) using it in as many places as possible and fund as many studies as we can afford. The more the better to further the idea of a viable alternative to opioids and to establish RRx as a Standard-of-Care.

Here is the official website for CMS.gov. Medicare & Medicaid Services. Wade into the murky depths at your own risk. No lifeguard on duty.

https://medicarepaymentandreimbursement.com/2...s-and.html

Whether or not TENS is covered by insurance is indeterminate for me. I have tried to figure it out and got conflicting answers. If anyone has actual experience w/ this, or anything that sheds light on the whole insurance/CPT mystery, give me shout, please. It may have been at one time covered by CMS but now it seems to be on a case-by-case basis, however that is interpreted. The whole entire medical system was started by quacks and charlatans and continues to this very day. Money and control is first and foremost. Your good health is last, and in many cases, dead last.

I think now would be a good time to look at the competition. https://www.amazon.com/TENs-devices/s?k=TENs+devices - take a look at it, please. Several things can be learned examing all the available stuff. Each one has a controller, wires attached to pads (electrodes), controllers, and tubes of gel. Some of the brand names are: Belifu, Auvon, Neu medics, PUREMED, iReliev, iStim A6, Brilnurse, VPOD, Roscoe, Hollywog, MEDVICE, NURSAL, & MASTOGO. There were at least 6 more pages w/ even more brand names. Some packages included everything, others had bits and pieces for replacement. Controllers have a mash-up of dials, knobs, settings, etc. (on a 'smart' phone or separately) and is anybody's guess what works with what kind of ailment. No, thanks. I like the simplicity of my Actipatch. It works all the time, every time.

I don't know the origins of TENS or who was the first but this tangle of offerings can't be good; or not? Some of these had tens of thousands of 4-5 star ratings. One called 'TENS 7000' (made by Roscoe) had over 72,000 ratings, 79% w/ 5 stars! What to make of this? Is TENS that good? I don't really know as I have never used one. This one claims to have begun in 2008 but does not claim to have FDA clearance. For $29 (reg $37) you get 4 electrode pads, dual channel controller, a battery, 2 lead wires, user manual, and a carrying case. It does not say how long it will last and the legal disclaimer is enough to put anybody off.

TENS will never have what we have - Affordability, Convenience, Effectiveness (A.C.E.). For TENS, how portable is it? Can't use it for more than 60 min at a time w/ no claims to treat or heal the underlying reason for the chronic pain. Forget about wearing it discreetly to work; or while playing sports w/ it on; or wearing it continuously for 30 days, or wear it to bed. Adverse effects include painful vibration and tingling to actual skin burns to shoddy quality.

So, why are people buying all these TENS devices and giving it 5 star reviews? They are desperate to find relief, that's why. Chronic pain has been around for decades. Pills, lotions, gadgets & contraptions, injections are expensive, have limited and temporary effect, don't address the underlying issue, and many have dreadful, long-term side effects. It goes to show you to what lengths sufferers will go to for some relief. With insurance coverage, worldwide distribution network, and a continued awareness campaign (like Twitter currently, which is excellent), Actipatch & RRx will siphon off many TENS users much to the users' relief.

All the things I have mentioned above are addressed by BIEL's Actipatch and RecoveryRx, and all the other products we will offer. No adverse side effects ever reported in over a decade of use; full complete well-documented science in multiple studies easily available at bielcorp.com, more ongoing; well known companies as OEM partners (KT Tape, DonJoy, SAI, PRIM, etc.); available in 38 countries and many online outlets.

Assuming we do obtain a CPT I code (esp'ly RRx) this makes us a prime buyout/merger target; definitely on the auction block and in a very good way. Our value as a company would soar right off the page in a northward direction. I understand completely why the company will not just blurt out info in ref to where we are in the process. There is too much at stake. We still have to submit payment proposals to the insurance companies and negotiate from there. So there is work to be done. Counting chickens ... and all that. Seeing the finish line is no time to slacken the effort and assume victory. The last inch is as important as the first.

It is my belief BIEL will be successful in getting the CPT I code. If big pharma, AMA, FDA, had their way there would be no change at all. The medical establishment, especially in the last 2 yrs, has erased any credibility there might have been left over from the (ongoing) opioid disaster. As far as I'm concerned their collective reputation is in the toilet, where it belongs.

Let me say this in closing (about time!). Bringing in RecoveryRx as an antidote to the opioids would be a win-win-win. For the patients (w1); for us, the investors (w2); for the industry (w3). I'll leave you w/ these parting words -

BUY_MORE_SHARES

later, WBeacham

p.s. - if you are int'd in getting a copy of a prev post (R.I.P.) send me a pm.

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 5

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 7

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 4

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 4

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 4

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 2

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 8

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading

Top 5 Most Recently Viewed Articles

Getchell Gold Corp. Expands Potential with New Stock Options

Updated Category News Views 100

Getchell Gold Corp. Announcements on Stock Options Getchell Gold Corp. is excited to share some important updates regarding its recent activities that aim to bolster its market position and engage effectively with investors. The company has granted a total of 700,000 incentive stock options as part of its ongoing strategy to enhance value for its stakeholders. These...

Continue Reading
Celebrating Achievements of Hispanic Entrepreneurs and Community Growth

Updated Category News Views 39

Celebrating Achievements of Hispanic Entrepreneurs Recently, a significant event took place aimed at honoring the achievements of small Hispanic-owned businesses. This gathering emphasized the importance of support for local entrepreneurs and showcased what can be achieved when communities come together to uplift one another. Prospera's Annual Event Highlights At the...

Continue Reading
Explore Soil Health at the World Living Soils Forum 2026

Updated Category News Views 200

World Living Soils Forum Coming to LUMA Arles in 2026 A renewed commitment towards soil health Moët Hennessy, known for its prestigious wines and spirits, is thrilled to announce the upcoming third edition of the World Living Soils Forum (WLSF) scheduled for June 3 and 4, 2026, at LUMA Arles. This important gathering is co-organized with ChangeNOW and aims to strengthen...

Continue Reading
How Grant Cardone Believes Trump Can Transform Housing

Updated Category News Views 458

Grant Cardone on Housing Crisis Solutions Grant Cardone, the CEO of Cardone Capital, is gearing up for an important speaking engagement where he plans to discuss pressing financial topics. One of the central issues he aims to tackle is America’s escalating housing crisis, which he believes needs immediate attention. The Current State of the Housing Market Cardone...

Continue Reading
Innovative Collaboration to Revolutionize Electric Bus Industry

Updated Category News Views 251

Groundbreaking Partnership Between Foresight and Bumhan In an exciting development for the electric vehicle industry, Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX, TASE: FRSX.TA) has entered into a significant collaboration with Bumhan Motors Ltd., a prominent South Korean bus manufacturer. Together, they aim to not only enhance electric buses but also pave the way...

Continue Reading